Literature DB >> 15499061

Determinants of universal adolescent hepatitis B vaccine uptake.

L A Wallace1, J C Bramley, S Ahmed, R Duff, S J Hutchinson, W F Carman, N R E Kitchin, D J Goldberg.   

Abstract

The UK is currently considering the introduction of universal hepatitis B vaccination. This study of determinants of vaccine uptake among school based adolescents shows that living in areas of high deprivation, commonly associated with injecting drug risk behaviours, was the most important factor, with statistically significant lower odds of receiving three doses. This was less pronounced for receipt of two doses. Thus, there are implications for future policy; if universal vaccination is approved, a licensed two dose schedule would be most appropriate in this setting.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499061      PMCID: PMC1719704          DOI: 10.1136/adc.2003.043687

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Hepatitis B immunisation in Britain: time to change?

Authors:  Jangu Banatvala; Pierre Van Damme; Nedret Emiroglu
Journal:  BMJ       Date:  2006-04-08

2.  HPV vaccine: positive insights from universal adolescent HepB vaccination.

Authors:  J Claire Cameron; Lesley A Wallace; Syed Ahmed; Rina Duff; Martin Donaghy; David J Goldberg
Journal:  J Epidemiol Community Health       Date:  2007-12       Impact factor: 3.710

3.  Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study.

Authors:  Loretta Brabin; Stephen A Roberts; Rebecca Stretch; David Baxter; Gloria Chambers; Henry Kitchener; Rosemary McCann
Journal:  BMJ       Date:  2008-04-24

4.  Addressing health inequalities in the delivery of the human papillomavirus vaccination programme: examining the role of the school nurse.

Authors:  Tammy Boyce; Alison Holmes
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  Explaining variation in the uptake of HPV vaccination in England.

Authors:  Varun M Kumar; David K Whynes
Journal:  BMC Public Health       Date:  2011-03-22       Impact factor: 3.295

6.  Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression model.

Authors:  Eva Lefevere; Niel Hens; Frank De Smet; Pierre Van Damme
Journal:  BMC Public Health       Date:  2011-06-14       Impact factor: 3.295

7.  A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent.

Authors:  Loretta Brabin; Stephen A Roberts; Henry C Kitchener
Journal:  BMC Public Health       Date:  2007-02-09       Impact factor: 3.295

8.  Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK.

Authors:  M Kohli; N Ferko; A Martin; E L Franco; D Jenkins; S Gallivan; C Sherlaw-Johnson; M Drummond
Journal:  Br J Cancer       Date:  2006-12-05       Impact factor: 7.640

Review 9.  Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies.

Authors:  Victoria Fernández de Casadevante; Julita Gil Cuesta; Lourdes Cantarero-Arévalo
Journal:  Front Oncol       Date:  2015-06-24       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.